Skip to content
Search

Latest Stories

RPS Wales announces next steps for pharmacy’s 2030 vision

RPS Wales announces next steps for pharmacy’s 2030 vision

The RPS Wales Conference celebrated the significant progress made in pharmacy in Wales

RPS Wales will once again spearhead the development of new three-year goals to help pharmacy in Wales advance toward its 2030 vision as outlined in Pharmacy: Delivering a Healthier Wales (PDaHW).

Elen Jones, Director of RPS Wales, and Jonathan Simms, Chair of the Welsh Pharmaceutical Committee, announced during the recent RPS Wales Conference.


Jones said: “I’d like to thank the Welsh Government and the Welsh Pharmaceutical Committee for once again entrusting RPS to take this work forward.”

This iteration of PDaHW builds on the original 10-year plan, published in 2019, and the two series of stepping stone goals established from 2019-2022 and 2022-2025.

Work on the new three-year goals will begin in early 2025.

“As always, we want to make sure the new goals reflect the views and ambitions of pharmacy teams in Wales. Therefore, we will be hosting a number of engagement events across Wales so that everyone has an opportunity to have their voice heard,” Jones said.

In addition to the announcement regarding the next steps for the 2030 vision, the RPS Wales Conference celebrated the significant progress made in pharmacy in Wales.

The conference featured presentations on the strategic developments undertaken by Digital Health and Care Wales, Health Education and Improvement Wales, the newly established NHS Wales Joint Commissioning Committee, and an overview of the Transforming Access to Medicines (TRAMS) programme undertaken by the NHS Wales Shared Wales Services Partnership.

Another highlight of the conference was eight quick-fire PDaHW Trailblazer talks from pharmacists and pharmacy technicians from all over Wales, which highlighted high-quality and innovative practices aligned with the PDaHW vision.

Nearly 200 members of pharmacy teams from all over Wales attended the RPS Wales Conference.

Launched in 2019, the 2030 vision for pharmacy in Wales sets long term ambitions for how patients will benefit from the expertise of pharmacy teams. It also includes a number of interim, three-year goals that act as stepping-stones toward the vision

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less